Zepbound 5MG/0.5ML 4S
Ended Awarded Last action
- Contract number
- SPE2DR26FATRD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $81,959
Award facts
- Contract value 100% obligated
- $81,959.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at approximately $82K to AmerisourceBergen Drug Corp for the supply of Zepbound 5mg/0.5ml (semaglutide) in quantities of four units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 6, 2026, and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $1 billion through December 2026, which provides a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
The parent entity of the awardee is Cencora, Inc., which does business as AmerisourceBergen and holds the primary IDC with the Defense Logistics Agency. Zepbound is an injectable glucagon-like peptide-1 (GLP-1) receptor agonist used for weight management in eligible patients, reflecting the federal government's procurement of contemporary pharmaceutical treatments for military healthcare systems. The firm fixed-price structure and competitive award process underscore AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through its expansive distribution network and existing long-term IDC vehicle with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FATRD?
SPE2DR26FATRD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FATRD worth?
The government has obligated $81,959 on SPE2DR26FATRD.
Is contract SPE2DR26FATRD an order under another contract?
Yes. SPE2DR26FATRD is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FATRD competed?
The extent of competition for SPE2DR26FATRD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award